Gilead Sciences bags Descovy FDA approval for prevention of HIV infection
Descovy FDA approval : Gilead Sciences’ Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) has been approved by the US Food and Drug Administration for HIV Pre-Exposure Prophylaxis (PrEP) or in other words prevention of HIV infection.. PrEP is defined as an HIV prevention method in which medicine is taken everyday before […]
Biktarvy China approval : US biopharma company Gilead Sciences said that the China National Medical Products Administration (NMPA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF) for the treatment of HIV-1 infection. The once-daily single tablet regimen (STR) Biktarvy is a combination of the unboosted integrase strand transfer inhibitor (INSTI) bictegravir and the dual […]
Continue reading …Gilead Sciences licenses three preclinical antiviral programs from Novartis
July 22, 2019 No Comment
US biopharma company Gilead Sciences has licensed three preclinical antiviral programs, including investigational candidates having the potential to treat human rhinovirus, influenza and herpes viruses, from Swiss pharma company Novartis. As per the agreement, Gilead Sciences will get exclusive global rights for the development and commercialization of small molecules against three undisclosed targets. Novartis will […]
Continue reading …
US biopharma company Gilead Sciences has named Christi L. Shaw as the new chief executive officer of its subsidiary Kite, a California-based cell therapy company, which the former acquired for about $11.9 billion in 2017. Christi L. Shaw, who will also become a member of the senior leadership team of Gilead Sciences, is said to […]
Continue reading …
Business News Today
- Siemens Gamesa to acquire certain European assets of Senvion Group
- 3M to sell drug delivery business to Altaris Capital for $650m
- Constellation Brands, E. & J. Gallo Winery sign revised deal to address FTC concerns
- Nestlé to sell US ice cream business to Froneri for $4bn
- Vitol takes full ownership in asphalt trading business VALT
- Vitol signs deal with NLNG to buy Nigerian LNG from 2021
- Ærfugl project phase 2 : Aker Solutions bags contract for subsea production system
- Lilly launches LIBRETTO-431 clinical trial for selpercatinib in NSCLC
- Leucadia launches Sodium Tetradecyl Sulfate injection for varicose veins
- Pure Aqua to deliver industrial desalination systems for Saudi Arabia
